isoxazoles has been researched along with Adult Spinal Muscular Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisold, A | 1 |
| Androphy, EJ; Boaler, PJ; Burnett, BG; Calder, AN; Cherry, JJ; Choi, S; Cuny, GD; Fritsche, M; Glicksman, MA; Hodgetts, KJ; Kern, NL; Li, H; Lorson, CL; Lusic, H; Quist, KM; Rietz, A; Xing, X | 1 |
2 other study(ies) available for isoxazoles and Adult Spinal Muscular Atrophy
| Article | Year |
|---|---|
Upcoming market catalysts in Q3 2020.
Topics: Angelman Syndrome; Azo Compounds; Drug Approval; Fatty Acids; Humans; Isoxazoles; Muscular Atrophy, Spinal; Pyrimidines; Triglycerides; United States | 2020 |
Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy.
Topics: Anilides; Area Under Curve; Benzamides; Cell Line; Drug Discovery; Half-Life; Humans; Isoxazoles; Molecular Probes; Muscular Atrophy, Spinal; Protein Processing, Post-Translational; Protein Stability; Quinolones; Structure-Activity Relationship; Survival of Motor Neuron 1 Protein; Thiazoles | 2017 |